Cargando…

Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors

Mitochondria are the main bioenergetic organelles of cells. Exposure to chemicals targeting mitochondria therefore generally results in the development of toxicity. The cellular response to perturbations in cellular energy production is a balance between adaptation, by reorganisation and organelle b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Huan, van der Stel, Wanda, Lee, Randy, Bauch, Caroline, Bevan, Sam, Walker, Paul, van de Water, Bob, Danen, Erik H. J., Beltman, Joost B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416757/
https://www.ncbi.nlm.nih.gov/pubmed/34489692
http://dx.doi.org/10.3389/fphar.2021.679407
_version_ 1783748253656809472
author Yang, Huan
van der Stel, Wanda
Lee, Randy
Bauch, Caroline
Bevan, Sam
Walker, Paul
van de Water, Bob
Danen, Erik H. J.
Beltman, Joost B.
author_facet Yang, Huan
van der Stel, Wanda
Lee, Randy
Bauch, Caroline
Bevan, Sam
Walker, Paul
van de Water, Bob
Danen, Erik H. J.
Beltman, Joost B.
author_sort Yang, Huan
collection PubMed
description Mitochondria are the main bioenergetic organelles of cells. Exposure to chemicals targeting mitochondria therefore generally results in the development of toxicity. The cellular response to perturbations in cellular energy production is a balance between adaptation, by reorganisation and organelle biogenesis, and sacrifice, in the form of cell death. In homeostatic conditions, aerobic mitochondrial energy production requires the maintenance of a mitochondrial membrane potential (MMP). Chemicals can perturb this MMP, and the extent of this perturbation depends both on the pharmacokinetics of the chemicals and on downstream MMP dynamics. Here we obtain a quantitative understanding of mitochondrial adaptation upon exposure to various mitochondrial respiration inhibitors by applying mathematical modeling to partially published high-content imaging time-lapse confocal imaging data, focusing on MMP dynamics in HepG2 cells over a period of 24 h. The MMP was perturbed using a set of 24 compounds, either acting as uncoupler or as mitochondrial complex inhibitor targeting complex I, II, III or V. To characterize the effect of chemical exposure on MMP dynamics, we adapted an existing differential equation model and fitted this model to the observed MMP dynamics. Complex III inhibitor data were better described by the model than complex I data. Incorporation of pharmacokinetic decay into the model was required to obtain a proper fit for the uncoupler FCCP. Furthermore, oligomycin (complex V inhibitor) model fits were improved by either combining pharmacokinetic (PK) decay and ion leakage or a concentration-dependent decay. Subsequent mass spectrometry measurements showed that FCCP had a significant decay in its PK profile as predicted by the model. Moreover, the measured oligomycin PK profile exhibited only a limited decay at high concentration, whereas at low concentrations the compound remained below the detection limit within cells. This is consistent with the hypothesis that oligomycin exhibits a concentration-dependent decay, yet awaits further experimental verification with more sensitive detection methods. Overall, we show that there is a complex interplay between PK and MMP dynamics within mitochondria and that data-driven modeling is a powerful combination to unravel such complexity.
format Online
Article
Text
id pubmed-8416757
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84167572021-09-05 Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors Yang, Huan van der Stel, Wanda Lee, Randy Bauch, Caroline Bevan, Sam Walker, Paul van de Water, Bob Danen, Erik H. J. Beltman, Joost B. Front Pharmacol Pharmacology Mitochondria are the main bioenergetic organelles of cells. Exposure to chemicals targeting mitochondria therefore generally results in the development of toxicity. The cellular response to perturbations in cellular energy production is a balance between adaptation, by reorganisation and organelle biogenesis, and sacrifice, in the form of cell death. In homeostatic conditions, aerobic mitochondrial energy production requires the maintenance of a mitochondrial membrane potential (MMP). Chemicals can perturb this MMP, and the extent of this perturbation depends both on the pharmacokinetics of the chemicals and on downstream MMP dynamics. Here we obtain a quantitative understanding of mitochondrial adaptation upon exposure to various mitochondrial respiration inhibitors by applying mathematical modeling to partially published high-content imaging time-lapse confocal imaging data, focusing on MMP dynamics in HepG2 cells over a period of 24 h. The MMP was perturbed using a set of 24 compounds, either acting as uncoupler or as mitochondrial complex inhibitor targeting complex I, II, III or V. To characterize the effect of chemical exposure on MMP dynamics, we adapted an existing differential equation model and fitted this model to the observed MMP dynamics. Complex III inhibitor data were better described by the model than complex I data. Incorporation of pharmacokinetic decay into the model was required to obtain a proper fit for the uncoupler FCCP. Furthermore, oligomycin (complex V inhibitor) model fits were improved by either combining pharmacokinetic (PK) decay and ion leakage or a concentration-dependent decay. Subsequent mass spectrometry measurements showed that FCCP had a significant decay in its PK profile as predicted by the model. Moreover, the measured oligomycin PK profile exhibited only a limited decay at high concentration, whereas at low concentrations the compound remained below the detection limit within cells. This is consistent with the hypothesis that oligomycin exhibits a concentration-dependent decay, yet awaits further experimental verification with more sensitive detection methods. Overall, we show that there is a complex interplay between PK and MMP dynamics within mitochondria and that data-driven modeling is a powerful combination to unravel such complexity. Frontiers Media S.A. 2021-08-19 /pmc/articles/PMC8416757/ /pubmed/34489692 http://dx.doi.org/10.3389/fphar.2021.679407 Text en Copyright © 2021 Yang, van der Stel, Lee, Bauch, Bevan, Walker, van de Water, Danen and Beltman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yang, Huan
van der Stel, Wanda
Lee, Randy
Bauch, Caroline
Bevan, Sam
Walker, Paul
van de Water, Bob
Danen, Erik H. J.
Beltman, Joost B.
Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors
title Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors
title_full Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors
title_fullStr Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors
title_full_unstemmed Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors
title_short Dynamic Modeling of Mitochondrial Membrane Potential Upon Exposure to Mitochondrial Inhibitors
title_sort dynamic modeling of mitochondrial membrane potential upon exposure to mitochondrial inhibitors
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416757/
https://www.ncbi.nlm.nih.gov/pubmed/34489692
http://dx.doi.org/10.3389/fphar.2021.679407
work_keys_str_mv AT yanghuan dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT vanderstelwanda dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT leerandy dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT bauchcaroline dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT bevansam dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT walkerpaul dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT vandewaterbob dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT danenerikhj dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors
AT beltmanjoostb dynamicmodelingofmitochondrialmembranepotentialuponexposuretomitochondrialinhibitors